0120 mg blend certificate
BPC-157/TB-500
- Bundle unit
- 20 mg blend vial
- Certificate sample
- Labeled content 20
- Reported purity
- 99.66%
- Lot
- BTB-090226-10
Two-product set
Research bundle · fixed set
$189.98$170.98SAVE 10%STACK BUNDLE
Wolverine Stack
A two-product set for laboratory research: one 20 mg BPC-157/TB-500 blend vial and one separate 10 mg KPV vial. The blend is not two vials, and the set is not one combined mechanism.
BPC-157/TB-50020 mg blend · one vial
KPV10 mg · one vial
You save $19.00. The 10% bundle price is shown again in your cart and checkout.
For laboratory research use only. Not for human or veterinary use. Not a subscription.
About this set
Wolverine Stack is a fixed set of two catalog products. The first is a single 20 mg vial that already contains two peptide identities, BPC-157 and TB-500. The second is a separate 10 mg KPV vial. Each product keeps its own identity, labeled strength, and certificate record. Components cannot be removed or swapped in this version. Buying the set does not create a new combined mechanism.
BPC-157/TB-500 20 mg blend vial · KPV 10 mg vial
- Set
- Two products, two vials
- Form
- Lyophilized powder
- Bundle price
- $170.98
- Saving
- 10% off the two singles
Independent documentation
Two products. Two certificate records.
Open the certificate associated with each product. Certificates report the specific sample and lot tested. The blend document covers both peptide identities inside the one 20 mg vial.
0210 mg certificate
KPV
- Bundle unit
- 10 mg
- Certificate sample
- 10 mg
- Reported purity
- 99.269%
- Lot
- KPV12222025-J
Certificate scope: Results apply only to the sample and lot identified in each document. The blend certificate reports BPC-157 at 10.49 mg and thymosin beta-4 at 10.83 mg in that sample (21.32 mg total) against labeled content 20. A lot-specific certificate should be checked against the vial received before research begins.
0
Products
Blend vial plus KPV
0
Vials in the set
One blend vial, one KPV vial
0%
Bundle saving
$170.98 instead of $189.98
0
Certificate records
Both match the labeled units
How It Works
How the two products are studied
Each product is cataloged on its own research pathway. The diagram names the two included products. It does not describe a combined mechanism. BPC-157 and TB-500 are identities inside one vial, not two extra vials.
Two research materials · illustrative
BPC-157/TB-500 · 20 mg
One blend vial
Two peptide identities ship in this single vial. Catalog research has measured growth-factor pathway endpoints for BPC-157 and actin-binding endpoints for TB-500. Those records stay separate.
- One 20 mg blend vial, not two vials
- Labeled-content 20 certificate, lot BTB-090226-10
- Open the blend record
KPV · 10 mg
Separate vial
KPV is the Lys-Pro-Val tripeptide from the tail of alpha-MSH. Laboratory work has measured an effect on NF-κB signalling. It is not part of the blend vial.
- One 10 mg vial
- 10 mg certificate, lot KPV12222025-J
- Open the KPV record
Uses & Applications
What each product is researched for
The set covers two catalog research areas. A shared shipment does not make the products interchangeable, and it does not merge the blend into a third compound.
Two identities, one vial
BPC-157 is studied at growth-factor pathways. TB-500 is studied at actin, the protein that gives cells their shape and lets them move in culture. Researchers compare the blend with the single compounds. The pair has not been characterised as one formulation.
NF-κB signalling models
KPV is studied as the C-terminal tripeptide of alpha-MSH. Published work measures NF-κB and MAP-kinase signalling in cell and animal models. It is a separate 10 mg vial in this set.
Compound identities
Three identities, two vials
BPC-157 and TB-500 are both inside the 20 mg blend vial. KPV is the second vial. This set is not one molecule.
BPC-157 · inside the blend
TB-500 · inside the blend
KPV · 10 mg vial
How the vials ship
Compound Information
Full specification
| Set | One 20 mg BPC-157/TB-500 blend vial and one 10 mg KPV vial |
| BPC-157 identity | C62H98N16O22 · 1419.53 g/mol · CAS 137525-51-0 · 15 residues |
| BPC-157 sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| TB-500 identity | C212H350N56O78S · 4963.44 g/mol · 43 residues · same blend vial |
| KPV identity | 10 mg · 1 vial · C16H31N5O4 · 342.43 g/mol · Lys-Pro-Val |
| Form | Lyophilized powder |
| Purchase | Fixed set. One-time purchase only. Components cannot be removed. |
| Price | $170.98 · 10% off $189.98 |
| Testing | Third-party HPLC on each published certificate |
| Blend certificate | Labeled content 20 · 99.66% · lot BTB-090226-10 · reported 09/08/2026 |
| Blend sample amounts | BPC-157 10.49 mg · thymosin beta-4 10.83 mg · total 21.32 mg |
| KPV certificate | 10 mg · 99.269% · lot KPV12222025-J · net peptide 12.49 mg |
| Storage | -20°C, protected from light and moisture |
| Use | In-vitro laboratory research only |
FAQ
Common questions about the Wolverine Stack
No. This version is a fixed two-product set. The blend vial and the KPV vial both ship. Customizable boxes are being developed separately.
No. BPC-157 and TB-500 ship together as one 20 mg blend vial. KPV is the second vial. The set contains two vials, not three.
No. Wolverine Stack is a one-time purchase. There is no recurring billing option on this page.
The published blend certificate, lot BTB-090226-10, lists labeled content 20 and purity 99.66%. The same page reports 10.49 mg BPC-157 and 10.83 mg thymosin beta-4 in that sample. The published KPV certificate, lot KPV12222025-J, is a 10 mg record at 99.269% purity, with net peptide content 12.49 mg. Neither document is a different labeled strength from the unit in this set.
Match the lot identifier on each vial against its accompanying certificate or the COA Library. Contact support if a lot-specific document is not available.
Store each lyophilized vial at -20°C, protected from light and moisture. Follow the storage note on the individual product record if it is more specific.
Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.